Renaissance Technologies’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.41M Buy
4,887,200
+1,375,800
+39% +$2.37M 0.01% 1179
2025
Q1
$11.7M Buy
+3,511,400
New +$11.7M 0.02% 926
2023
Q4
Sell
-1,226,400
Closed -$5.58M 3904
2023
Q3
$5.58M Sell
1,226,400
-506,300
-29% -$2.3M 0.01% 1236
2023
Q2
$12.2M Sell
1,732,700
-142,800
-8% -$1.01M 0.02% 925
2023
Q1
$11.5M Sell
1,875,500
-1,325,400
-41% -$8.1M 0.02% 1023
2022
Q4
$20.5M Buy
3,200,900
+2,392,300
+296% +$15.3M 0.03% 699
2022
Q3
$7.75M Buy
+808,600
New +$7.75M 0.01% 1166
2022
Q1
Sell
-270,000
Closed -$5.15M 4255
2021
Q4
$5.15M Buy
+270,000
New +$5.15M 0.01% 1513
2021
Q2
Sell
-140,600
Closed -$4.45M 3616
2021
Q1
$4.45M Buy
+140,600
New +$4.45M 0.01% 1718
2019
Q4
Sell
-61,400
Closed -$1.12M 3616
2019
Q3
$1.12M Buy
+61,400
New +$1.12M ﹤0.01% 2553
2016
Q4
Sell
-19,000
Closed -$156K 3344
2016
Q3
$156K Buy
+19,000
New +$156K ﹤0.01% 3110